Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-22

Clinical Trial Update: Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida [Phase 3]

View source ↗

Summary

Phase 3 trial comparing tranexamic acid to misoprostol for reducing blood loss during cesarean section in primigravida completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MISOPROSTOL (Misoprostol)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Cairo University | Conditions: Cesarean Section Complications, Blood Loss, Surgical | Phase 3 | Status: COMPLETED